Strategic Opportunity Leverage Free Flow Medical’s next generation coil technology and recent ISO and CE approvals to target large COPD and emphysema treatment programs, positioning as a preferred device partner for early adopters seeking improved patient outcomes.

Clinical Partnerships Engage their network of top US and European clinical experts to facilitate site introductions, investigator-initiated studies, and co-marketing opportunities with leading COPD centers to accelerate adoption.

R&D Financing Explore collaboration or grant-supported funding models to support continued patenting and pipeline expansion, aligning with their modest current funding and revenue to scale manufacturing and distribution.

Regulatory Readiness Highlight compatibility with existing regulatory milestones and emphasize post-CE market access strategies to simplify hospital procurement and accelerate time-to-adoption in priority markets.

Strategic Fit Position complementary device and service bundles with major medical distributors or device groups to align with their scale considerations and leverage their niche focus in high-need COPD care.